We are live on
!
Find out more
AFA
Abacus FCF Advisors Portfolio holdings
AUM
$444M
1-Year Est. Return
44.44%
This Fund
S&P 500
This Quarter
Est. Return
+13.79%
1 Year Est. Return
+44.44%
3 Year Est. Return
+142.32%
5 Year Est. Return
+208.76%
10 Year Est. Return
–
AUM
$203M
AUM Growth
-$2.63M
(-1.3%)
Cap. Flow
-$17.8M
Cap. Flow
% of AUM
-8.76%
Top 10 Holdings %
Top 10 Hldgs %
22.47%
Holding
140
New
7
Increased
8
Reduced
27
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.59M |
| 2 |
Qualcomm
QCOM
|
+$1.33M |
| 3 |
VeriSign
VRSN
|
+$1.16M |
| 4 |
Simon Property Group
SPG
|
+$1.15M |
| 5 |
Microsoft
MSFT
|
+$1.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$1.96M |
| 2 |
TJX Companies
TJX
|
+$1.59M |
| 3 |
ResMed
RMD
|
+$1.49M |
| 4 |
Apple
AAPL
|
+$1.28M |
| 5 |
SGI
Somnigroup International
SGI
|
+$1.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.78% |
| 2 | Financials | 15.73% |
| 3 | Healthcare | 11.86% |
| 4 | Consumer Discretionary | 9.26% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMED
126
DELISTED
Amedisys
AMED
| – | – |
-2,087
| Closed | -$324K |
|
127
AstraZeneca
AZN
$269B
| – | – |
-8,035
| Closed | -$969K |
|
128
Brunswick
BC
$5.23B
| – | – |
-5,394
| Closed | -$527K |
|
129
Cardinal Health
CAH
$53.7B
| – | – |
-14,060
| Closed | -$719K |
|
130
Deckers Outdoor
DECK
$14.1B
| – | – |
-9,888
| Closed | -$640K |
|
131
Ford
F
$60.9B
| – | – |
-64,295
| Closed | -$885K |
|
132
First Horizon
FHN
$12.2B
| – | – |
-50,596
| Closed | -$813K |
|
133
Parker-Hannifin
PH
$120B
| – | – |
-3,700
| Closed | -$1.06M |
|
134
Polaris
PII
$3.83B
| – | – |
-7,296
| Closed | -$881K |
|
|
135
ResMed
RMD
$31.1B
| – | – |
-5,330
| Closed | -$1.49M |
|
|
136
TJX Companies
TJX
$179B
| – | – |
-22,411
| Closed | -$1.59M |
|
137
Walmart Inc
WMT
$909B
| – | – |
-21,528
| Closed | -$1.03M |
|
138
Yeti Holdings
YETI
$3.87B
| – | – |
-10,782
| Closed | -$1.03M |
|
139
Zoom
ZM
$27.1B
| – | – |
-2,627
| Closed | -$715K |
|
|
SGI
140
Somnigroup International
SGI
$14.4B
| – | – |
-23,021
| Closed | -$1.14M |
|
Similar funds
SGCM
WCP
ACA
JDLA
FWSM
MLIC
BI
TC
Abacus FCF Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, Abacus FCF Advisors held 140 positions worth $203M, down 1.3% from $206M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Abacus FCF Advisors withdrew a net $17.8M in Q4 2021, closing 17 positions and reducing 27 holdings. Its most notable exit was Adobe, an estimated $1.96M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Abacus FCF Advisors opened a new position in Pfizer worth $3.09M.
- Abacus FCF Advisors's largest Q4 2021 buy was Pfizer: 52,346 shares worth $3.09M.
- Abacus FCF Advisors added most to Microsoft in Q4 2021, an estimated $1.14M increase.
- Abacus FCF Advisors's biggest Q4 2021 reduction was Apple, cutting an estimated $1.28M.
- Abacus FCF Advisors fully exited Adobe in Q4 2021, selling an estimated $1.96M.
- Abacus FCF Advisors's ten largest holdings make up 22% of its $203M portfolio in Q4 2021.
- Abacus FCF Advisors opened 7 new positions and closed 17 in Q4 2021.
- Abacus FCF Advisors's portfolio value fell 1.3% quarter-over-quarter to $203M.
Based on Abacus FCF Advisors's 13F filing for Q4 2021, filed 10 Jan 2022.